; (ii) have in effect a registration or waiver under section 303(g) of the Controlled Substances Act for purposes of dispensing narcotic drugs to individuals for maintenance treatment or detoxification treatment and are in compliance with any regulation promulgated by the Assistant Secretary for Mental Health and Substance Use for purposes of carrying out the requirements of such section 303(g); and (iii) are licensed or certified under applicable State law to provide substance use disorder treatment and recovery services. (D) Activities that specifically expand, including through the provision of incentives, the number of providers participating under the State plan (or waiver) that have the qualifications to address the treatment and recovery needs of— (i) individuals enrolled under the State plan (or a waiver of such plan) who have neonatal abstinence syndrome, in accordance with guidelines issued by the American Academy of Pediatrics and American College of Obstetricians and Gynecologists relating to maternal care and infant care with respect to neonatal abstinence syndrome; (ii) postpartum women and infants, particularly the concurrent treatment and comprehensive case management of post­partum women and infants, enrolled under the State plan (or a waiver of such plan); (iii) adolescents and young adults between the ages of 12 and 21 enrolled under the State plan (or a waiver of such plan); or (iv) American Indian and Alaska Native individuals enrolled under the State plan (or a waiver of such plan). (2) Eligible States (A) Definition For purposes of this subsection, the term eligible State means a State selected by the Secretary under subparagraph (B). (B) Selection For purposes of this subsection, the Secretary shall select 10 States that meet the criteria for eligibility under subparagraph (C). In selecting such States, the Secretary shall— (i) select States in a manner that ensures geographic diversity